Polus Inc. announced a private placement of 15th series unregistered coupon unguaranteed private convertible bonds for gross proceeds of KRW 18,000,000,000 on August 27, 2018 The transaction will include participation from existing investor POLUS BioPharm Inc. (KOSE:A007630). The bonds are issued at par. The bonds are not carrying any coupon rate. The bonds have yield to maturity of 4% and would mature on August 28, 2021. The bonds are 100% converted into 1,636,363 common shares at a fixed conversion price of KRW 11,000 per share. The conversion period is from August 28, 2019 to July 28, 2021. The transaction has been approved by the board of directors of the company. The transaction is expected to close on August 28, 2018. The subscription date of the transaction is August 28, 2018.